The molecular mechanism by which SPRY4 exerts anti-cancer effects in perihilar cholangiocarcinoma is mainly related to ERK phosphorylation, which inhibits cell proliferation and migration. This evidence concerns the gene SPRY4 and hilar cholangiocarcinoma.